Gastroenterology Doctors in American Fork, UT Accepting Medicare

3 Gastroenterology doctors found. Showing 1 - 3

Wynn H Hemmert, MD Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 36 N 1100 E, Suite A, American Fork, UT 84003 Phone: 801-772-0775    Fax: 801-772-1941

Mohammad M Alsolaiman, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1175 E 50 S Ste 221, American Fork, UT 84003 Phone: 801-772-0775    Fax: 801-418-0941

David J Frantz, MD, MS Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1175 E 50 S Ste 221, American Fork, UT 84003 Phone: 801-772-0775    Fax: 801-772-1941

News Archive

Health bills present formidable challenges to numbers crunchers

The House Democratic leadership is expected to unveil its health-overhaul legislation Thursday, the Associated Press reports. The next step will be for the merged bill - consolidated from three separate committee reports - to go to the Congressional Budget Office for a cost estimate, before lawmakers vote. In the Senate, Majority Leader Harry Reid is awaiting the CBO's analysis of his bill, before taking it to the floor (10/29).

Cup-feeding versus breast-feeding

Newborn infants who are cup-fed as at least part of their feeding regime, are more likely to be exclusively breast-fed when they leave hospital, but are no more likely to be breast-fed three or six months later, a team of Cochrane researchers have found.

Study compares immune responses of patients with and without kidney failure after COVID-19 vaccination

Death rates from COVID-19 are especially high in individuals with kidney failure who are on dialysis, making SARS-CoV-2 vaccination in this population a high priority.

NeuroVive presents clinical data of NVP018 for treatment of chronic hepatitis B infections at EASL

NeuroVive's anti-viral preclinical program, with compound designated NVP018, has generated significant data indicating that NVP018 has the potential to become an effective alternative or addition to current drugs for treating chronic hepatitis B infections.

Labopharm submits response to FDA for formulation of the antidepressant trazodone

Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced that it has submitted its response to the U.S. Food and Drug Administration's (FDA) complete response letter regarding the Company's novel formulation of the antidepressant trazodone.

Read more Medical News

› Verified 7 days ago